However, it has been shown that nicotinic acid can reduce atherosclerosis progression independently of its antidyslipidemic activity by activating GPR109A in immune cells67, thus boosting anti-inflammatory processes68. The gene discussed is HCAR2; the disease is atherosclerosis.